A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief

Photorefractive Keratectomy Clinical Trial

Official title:
A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief of Patients Status Post-Photorefractive Keratectomy: A Double-Masked Randomized Prospective Study

Status Completed

Clinical Trial Summary

The purpose of this study is to compare healing times and subjective pain level responses of nepafenac to placebo after photo refractive keratomileusis (PRK) surgery.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00330798
Study type	Interventional
Source	Alcon Research
Contact
Status	Completed
Phase	Phase 4
Start date	February 2006
Completion date	June 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04704518` - Phase IV Study to Evaluate the Efficacy of Lagricel® Ofteno PF Compared to Thealoz® Duo After Photorefractive Keratectomy (PRK)	Phase 4
Completed	`NCT04281004` - Processed Amniotic Fluid (PAF) Drops After Photorefractive Keratectomy (PRK)	Phase 1/Phase 2
Recruiting	`NCT05313425` - Effect of Ectoine After Photorefractive Keratectomy (PRK).
Recruiting	`NCT05477875` - Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control	Phase 2
Completed	`NCT05973253` - Evaluation of Efficacy and Safety of Topical 1% Medroxyprogesterone in the Corneal Epithelium Healing After PRK	Phase 2/Phase 3
Terminated	`NCT01381731` - A Double-masked, Randomized, Placebo-controlled,Pilot Study of Diquafosol Tetrasodium in Subjects Following Photorefractive Keratectomy (PRK)	Phase 2